Współczesna Onkologia

Full text

2/2026 vol. 30
Review paper

Clinical guidelines for the management of cytostatic extravasation in children

Patrycja Sosnowska-Sienkiewicz 1
,
Anna Łohynowicz 2
,
Danuta Januszkiewicz-Lewandowska 3

  1. Department of Paediatric Surgery, Medical University of Warsaw, Warsaw, Poland

  2. Karol Jonscher Clinical Hospital, Poznan University of Medical Sciences, Poznan, Poland

  3. Department of Paediatric Oncology, Haematology and Transplantology, Poznan University of Medical Sciences, Poznan, Poland

Contemp Oncol (Pozn) 2026; 30 (2): 103–109

DOI: https://doi.org/10.5114/wo.2026.163773
Data publikacji online: 2026/08/17
Article file
Clinical guidelines.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Pham TD, Tsunoyama T. Exploring extravasation in cancer patients. Cancers (Basel) 2024; 16: 2308.
  2. Corbett M, Marshall D, Harden M, Oddie S, Phillips R, McGuire W. Treating extravasation injuries in infants and young children: a scoping review and survey of UK NHS practice. BMC Pediatr 2019; 19: 6.
  3. Nguyen M, Borders L, Wesolow JT, Greene J. Chemotherapy extravasation causing soft-tissue necrosis mimicking infection: a longitudinal case study. Cureus 2024; 16: e55333.
  4. Boschi R, Rostagno E. Extravasation of antineoplastic agents: prevention and treatments. Pediatr Rep 2012; 4: e28.
  5. Paquette V, McGloin R, Northway T, Dezorzi P, Singh A, Carr R. Describing intravenous extravasation in children (DIVE study). Can J Hosp Pharm 2011; 64: 340-345.
  6. Matsumoto K, Ryushima Y, Sato J, Aizawa Y, Aoyama T, Akaishi Y, et al. Extravasation associated with cancer drug therapy: multidisciplinary guideline of the Japanese Society of Cancer Nursing, Japanese Society of Medical Oncology, and Japanese Society of Pharmaceutical Oncology. ESMO Open 2024; 9: 103932.
  7. Chmal-Jagiełło K, Jankowiak-Gracz H, Bicz M, Korczowska E, Bochniarz M. Standardy jakościowe w farmacji onkologicznej Polskiego Towarzystwa Farmaceutycznego. Polskie Towarzystwo Farmaceutyczne Warszawa 2018
  8. Grela-Wojewoda A, Wysocki WM. Wynaczynienie cytostatyków. Med Prakt 2024.
  9. Karim M, Boikess R, Swartz R, Cohen P. Dimethyl sulfoxide (DMSO): a solvent that may solve selected cutaneous clinical challenges. Arch Dermatol Res 2023; 315: 1465-1472.
  10. Kik K, Szmigiero L. Dexrazoxane (ICRF-187) – a cardioprotectant and modulator of action of some anticancer drugs. Postepy Hig Med Dosw 2006; 60: 584-590.
  11. Pasek M, Jobda B. Wynaczynienia leków przeciwnowotworowych: profilaktyka – postępowanie terapeutyczne – edukacja pacjentów. Rekomendacje Polskiego Stowarzyszenia Pielęgniarek Onkologicznych. Polskie Stowarzyszenie Pielęgniarek Onkologicznych, Warszawa 2017.
  12. Perez Fidalgo JA, Garcia Fabregat L, Cervantes A, Vidall C, Roila F. Management of chemotherapy extravasation: ESMO-EONS clinical practice guidelines. Ann Oncol 2012; 23: vii167-vii173.
  13. Rubach M. Management of extravasation of antineoplastic agents. Oncol Clin Pract 2018; 14: 15-22.
  14. Kreidieh FY, Moukadem HA, El Saghir NS. Overview, prevention and management of chemotherapy extravasation. World J Clin Oncol 2016; 7: 87-97.
  15. Duminuco A, Novello G, Mauro E, Scalisi E, del Fabrto V, Sambata- ro D, et al. Chemotherapy extravasation: diagnosis, prevention and management. J Chemother. Published 2026, 38.
  16. Koper A. Zalecenia krajowego konsultanta w dziedzinie pielęgniarstwa onkologicznego dotyczące postępowania pielęgniarskiego w przypadku wynaczynienia leku cytostatycznego. Okręgowa Izba Pielęgniarek i Położnych, Bydgoszcz 2016.
  17. Little M, Dupré S, Wormald JCR, Gardiner M, Gale C, Jain A. Surgical intervention for paediatric infusion-related extravasation injury: a systematic review. BMJ Open 2020; 10: e034950.
  18. Corbett M, Marshall D, Harden M, Oddie S, Phillips R, McGuire W. Treatment of extravasation injuries in infants and young children: a scoping review and survey. Health Technol Assess 2018; 22: 1-112.
  19. Cedidi C, Hierner R, Berger A. Plastic surgical management in tissue extravasation of cytotoxic agents in the upper extremity. Eur J Med Res 2001; 6: 309-314.
  20. Gault DT. Extravasation injuries. Br J Plast Surg 1993; 46: 91-96.
  21. Murphy PM, Gault DT. Treatment of extravasation injury. Anaesthesia 1990; 45: 600.
  22. Mas V, Simon AL, Presedo A, Mallet C, Ilharreborde B, Jehanno P. Upper limb extravasation of cytotoxic drugs: results of the saline washout technique in children. J Child Orthop 2020; 14: 230-235.
  23. Webb LX. New techniques in wound management: vacuum- assisted wound closure. J Am Acad Orthop Surg 2002; 10: 303-311.
  24. Lozzo AGD, Conca ADG, Hyon SH, Cardenas MP. Use of vacuum therapy in access port catheter extravasation of vesicant cytotoxic agents. J Lung Pulm Respir Res 2018; 5: 121-124.
  25. Braza ME, Marietta M, Fahrenkopf MP. Split-thickness skin grafts. In: StatPearls [Internet]. Treasure Island (FL): StatPearls 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK551561/ (accessed: 14.02.2025).
  26. Ramsey ML, Walker B, Marietta M, Patel BC. Full-thickness skin grafts. In: StatPearls [Internet]. Treasure Island (FL): StatPearls 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK 532875/ (accessed: 05.03.2025).
  27. Prohaska J, Sequeira Campos MB, Cook C. Rotation flaps. In: StatPearls [Internet]. Treasure Island (FL): StatPearls 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482371/ (accessed: 16.08.2023).
  28. Boretto JG, Hohman MH, De Cicco FL. Fasciocutaneous flaps. In: StatPearls [Internet]. Treasure Island (FL): StatPearls 2025. Available from: https://www.ncbi.nlm.nih.gov/books/NBK562280/ (accessed: 20.03.2024).
  29. Hashimoto I, Abe Y, Ishida S, Kashiwagi K, Mineda K, Yamashita Y, et al. Development of skin flaps for reconstructive surgery: random pattern flap to perforator flap. J Med Invest 2016; 63: 159-162.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Coverage in
Indexed in
pubmed
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications